Russian Federation
Accessed: 24.09.2019
Getting to Zero
Sustainable Financing of National HIV Responses
PLoS ONE 9(1): e87262. doi:10.1371/journal.pone.0087262
PLOS Medicine | https://doi.org/10.1371/journal.pmed.1002462 November 28, 2017
Advocacy achievements of the bridging the gaps global partners
Accessed: 17.11.2019
In case of resistance to rifampicin, fluoroquinolones become the preferred category of second-line drugs. Unfortunately, quinolone-resistant strains of Mycobacterium leprae have also been reported in several countries, probably due to the extensive use of quinolones for treating several types of inf...ections. Clofazimine resistance is still rare but this antimicrobial cannot be given alone
more
From passive beneficiaries to active agents of change